Motallebipour Mehdi, Enroth Stefan, Punga Tanel, Ameur Adam, Koch Christoph, Dunham Ian, Komorowski Jan, Ericsson Johan, Wadelius Claes
Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
FEBS J. 2009 Apr;276(7):1878-90. doi: 10.1111/j.1742-4658.2009.06914.x.
Sterol regulatory element-binding proteins 1 and 2 (SREBP-1 and SREBP-2) are important regulators of genes involved in cholesterol and fatty acid metabolism, but have also been implicated in the regulation of the cell cycle and have been associated with the pathogenesis of type 2 diabetes, atherosclerosis and obesity, among others. In this study, we aimed to characterize the binding sites of SREBP-1 and RNA polymerase II through chromatin immunoprecipitation and microarray analysis in 1% of the human genome, as defined by the Encyclopaedia of DNA Elements consortium, in a hepatocellular carcinoma cell line (HepG2). Our data identified novel binding sites for SREBP-1 in genes directly or indirectly involved in cholesterol metabolism, e.g. apolipoprotein C-III (APOC3). The most interesting biological findings were the binding sites for SREBP-1 in genes for host cell factor C1 (HCFC1), involved in cell cycle regulation, and for filamin A (FLNA). For RNA polymerase II, we found binding sites at classical promoters, but also in intergenic and intragenic regions. Furthermore, we found evidence of sterol-regulated binding of SREBP-1 and RNA polymerase II to HCFC1 and FLNA. From the results of this work, we infer that SREBP-1 may be involved in processes other than lipid metabolism.
固醇调节元件结合蛋白1和2(SREBP - 1和SREBP - 2)是参与胆固醇和脂肪酸代谢的基因的重要调节因子,但也与细胞周期调节有关,并与2型糖尿病、动脉粥样硬化和肥胖等疾病的发病机制相关。在本研究中,我们旨在通过染色质免疫沉淀和微阵列分析,在肝细胞癌细胞系(HepG2)中,对由DNA元件百科全书联盟定义的人类基因组的1%中SREBP - 1和RNA聚合酶II的结合位点进行表征。我们的数据在直接或间接参与胆固醇代谢的基因中,如载脂蛋白C - III(APOC3),鉴定出了SREBP - 1的新结合位点。最有趣的生物学发现是,在参与细胞周期调节的宿主细胞因子C1(HCFC1)基因和细丝蛋白A(FLNA)基因中发现了SREBP - 1的结合位点。对于RNA聚合酶II,我们在经典启动子以及基因间和基因内区域都发现了结合位点。此外,我们发现了SREBP - 1和RNA聚合酶II对HCFC1和FLNA的固醇调节结合的证据。从这项工作的结果来看,我们推断SREBP - 1可能参与脂质代谢以外的其他过程。